Financials in USD. Standardized financial statements.
A compact view of how Outset Medical, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $119.48M | $113.69M | $130.38M | $115.38M | $102.60M | $49.94M | $15.08M | $2.01M |
| Revenue Growth? | +5.1% | -12.8% | +13.0% | +12.4% | +105.5% | +231.2% | +651.3% | 0.0% |
| Cost of Revenue? | $72.72M | $75.13M | $101.38M | $97.54M | $94.99M | $62.97M | $32.88M | $8.12M |
| Gross Profit? | $46.75M | $38.56M | $29.00M | $17.83M | $7.61M | -$13.04M | -$17.80M | -$6.12M |
| Gross Margin? | +39.1% | +33.9% | +22.2% | +15.5% | +7.4% | -26.1% | -118.1% | -304.7% |
| Operating Expenses? | $113.46M | $151.94M | $198.77M | $178.85M | $138.13M | $104.43M | $52.51M | $40.45M |
| Operating Income? | -$66.71M | -$113.38M | -$169.77M | -$161.02M | -$130.52M | -$117.47M | -$70.31M | -$46.56M |
| EBITDA? | -$62.37M | -$97.89M | -$153.79M | -$152.81M | -$124.86M | -$114.85M | -$62.09M | -$43.62M |
| Income Before Tax | -$80.94M | -$127.48M | -$172.27M | -$162.66M | -$131.74M | -$121.49M | -$68.28M | -$49.76M |
| Income Tax Expense | $718,000 | $491,000 | $523,000 | $295,000 | $199,000 | $0 | $20,000 | $25,000 |
| Net Income? | -$81.65M | -$127.98M | -$172.80M | -$162.96M | -$131.94M | -$121.49M | -$68.30M | -$49.78M |
| EPS? | $-5.37 | $-36.95 | $-52.27 | $-50.75 | $-43.41 | $-2.83 | $-1.61 | $-1.65 |
| Diluted EPS? | $-5.37 | $-36.95 | $-52.27 | $-50.75 | $-43.41 | $-2.83 | $-34.06 | $-1.65 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality